Jordan Gauthier, MD^1,2, Bianca Furtuna^3*, Jacopo Mangiavacchi^3*, Shahrzad Gholami^3*, Juan Lavista Ferres^3*, Rahul Dodhia^3*, Amir T. Fathi, MD^4,5, Andrew M. Brunner, MD⁶, Aaron T. Gerds, MD, MS⁷, Mikkael A. Sekeres, MD⁸, Bruno C. Medeiros, MD⁹, Eunice S. Wang, MD¹⁰, Paul J Shami, MD¹¹, Kehinde Adekola, MBBS, MS¹², Selina M. Luger, MD, FRCPC¹³, Maria R. Baer, MD¹⁴, David A Rizzieri, MD¹⁵, Tanya Wildes, MD, MSc¹⁶, Jamie L. Koprivnikar, MD¹⁷, Julie Smith, MD^18*, Mitchell A. Garrison, MD^19*, Kiarash Kojouri, MD^20*, Frederick R. Appelbaum, MD^2,21, Mary-Elizabeth M. Percival, MD^22,23, Stephanie J. Lee, MD, MPH^24,25 and Mohamed L. Sorror, MD, MSc^26,27

¹Fred Hutchinson Cancer Research Center, Seattle, WA, USA, Seattle, WA
²Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
³Microsoft, Seattle
⁴Director of Leukemia Program, Massachusetts General Hospital, Boston, MA
⁵Associate Professor of Medicine, Harvard Medical School, Boston, MA
⁶Dana-Farber Cancer Institute, Boston, MA
⁷Department of Hematology and Medical Oncology,, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁸University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
⁹Department of Medicine, Division of Hematology, Stanford University School Medicine, Stanford, CA
¹⁰Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹¹Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹²Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
¹³Cellular Therapy and Transplantation, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
¹⁴University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
¹⁵Dept. of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC
¹⁶University of Nebraska Medical Center, Omaha, NE
¹⁷Georgetown University Hospital, Hackensack, NJ
¹⁸Confluence Health/Wenatchee Valley Hospital, Wenatchee, WA
¹⁹Confluence Health/Wenatchee Valley Hospital and Clinic, Wenatchee, WA
²⁰Skagit Valley Hospital Regional Cancer Care Center, Mount Vernon, WA
²¹Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
²²Department of Medicine, University of Washington, Seattle, WA
²³Fred Hutchinson Cancer Center, Seattle, WA
²⁴Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA
²⁵Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
²⁶Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA
²⁷Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA

Zack Pemberton-Whiteley^1*, Samantha Nier^1*, Nick York^2*, Deborah Baker^3*, Michael Rynne^3*, Nicole Schroeter^3*, Denis Costello^4*, Lidija Pecova^5*, Esther Natalie Oliva, MD⁶, Tatiana I. Ionova, Prof.⁷, Sam Salek, PhD RPh FFPM MCMS MRPSGB FESCP^8* and Jennie Bradley^9*

¹Acute Leukemia Advocates Network, Bern, Switzerland
²CLLAN - CLL Advocates Network, Bern, Switzerland
³CLL Advocates Network, Bern, Switzerland
⁴CML Advocates Network, Bern, Switzerland
⁵CML Advocates Network, bern, Switzerland
⁶Division of Hematology, Azienda Ospedaliena (B-M-M), Reggio Calabria, Italy
⁷University Clinic, St. Petersburg State University and Multinational Center for Quality of Life Research, Saint-Petersburg, Russia
⁸University of Hertfordshire, School of Life and Medical Sciences, Hatfield, United Kingdom
⁹IQVIA, Chesterfield, ENG, United Kingdom

Noha Sharafeldin, MBBCh, PhD, MSc^1,2,3, Donna Murdaugh, PhD^3*, Andie Grimm, MPH, CHES^4*, Sylvia Cartagena^4*, Victoria Seghatol-Eslami^4*, Nora Balas, MSPH^4*, Liton F. Francisco, BS^3*, Lindsey Hageman, MPH^3*, Joshua Richman, MD, PhD^5* and Smita Bhatia, MD, MPH^3,6

¹O'Neal Comprehensive Cancer Center, Birmingham, AL
²Medicine, Hematology & Oncology Division, UAB, Birmingham
³Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
⁴University of Alabama at Birmingham, Birmingham
⁵Institute for Cancer Outcomes and Survivorship, University of Alabama Birmingham, Birmingham, AL
⁶Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL

Eshana Shah, MD¹, Ana Maria Avila, MD¹, Jerry W Luo, MD^2*, Tasha Chasson, MSW, LCSW^3*, Elizabeth Raigoza, LCSW^3*, Ana Gordon, LCSW, OSW-C^3*, Michael Berbaum, PhD^4*, Agatha Gallo, PhD^5* and Irum Khan, MBBS¹

¹Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
²Department of Internal Medicine, University of Ilinois at Chicago, Chicago, IL
³Health Social Work, University of Ilinois Hospital & Health Sciences System, Chicago, IL
⁴School of Public Health, University of Ilinois Hospital & Health Sciences System, Chicago, IL
⁵College of Nursing, Department of Women, Children and Family Health Science, University of Illinois at Chicago, Chicago, IL

Fisihatsion Tadesse, MD¹, Amha Gebremedhin^1*, Abdulaziz Abubeker^1*, Alfonso Piciocchi, MS^2*, Marta Cipriani^2*, Lalise Gemechu^1*, Atalay Mulu, BPharm, MSPharm^1*, Getahun Asres^3* and Fabio Efficace, PhD^2*

¹Department of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
²Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy
³Department of Internal Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

Allicia Girvan, PhD^1*, Junhua Yu, PhD^1*, Nnadozie Emechebe, PhD^1*, Rajesh Kamalakar, MS^1* and Yan Luo, MD, PhD^2*

¹AbbVie, Inc., North Chicago, IL
²AbbVie Inc., North Chicago, IL

Jingbo Yu, MD, PhD¹, Michelle Jerry, MS^2*, James Nelson, PhD^2*, Taylor Marlin, MHI^2*, Evan Braunstein, MD, PhD^1* and Nicole Princic, MS^2*

¹Incyte Corporation, Wilmington, DE
²Merative, Ann Arbor, MI

Rong Wang, PhD^1,2*, Natalia Neparidze, MD^1,3, Xiaomei Ma, PhD^1*, Graham A Colditz, MD, DrPH^4*, Su-Hsin Chang, PhD^4* and Shi-Yi Wang, MD, PhD^5*

¹Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University School of Medicine, New Haven, CT
²Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT
³Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
⁴Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis School of Medicine, St Louis, MO
⁵Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT

Sikander Ailawadhi¹, Qiufei Ma^2*, Jessica J. Jalbert, PhD^2*, Mo Zhou, PhD^3*, Zheng-Yi Zhou, PhD^3*, Nathaniel Downes^3*, Adina Zhang^3*, Lei Chi^2*, Christian Hampp^2*, Xue Song^2*, Irene Noguera-Troise^2*, Jonathan Weyne, MD^2*, Glenn S. Kroog, MD^2* and Karen Rodriguez Lorenc, MD²

¹Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL
²Regeneron Pharmaceuticals, Inc., Tarrytown, NY
³Analysis Group, Inc., Boston, MA

Mycal Casey, DO, MPH¹, Lorriane Odhiambo, PhD, MPH^2*, Nidhi Aggarwal, BS³, Mahran Shoukier, MD^4*, KM Islam, MD, PhD^2* and Jorge E. Cortes, MD⁵

¹Internal Medicine, Medical College of Georgia At Augusta University, Augusta, GA
²Institute of Public Health and Preventive Health, Augusta University, Augusta, GA
³Medical College of Georgia, Statesboro, GA
⁴Georgia Cancer Center, Augusta University, Augusta, GA
⁵Georgia Cancer Center, Augusta, GA

John Mascarenhas, MD¹, Claire N. Harrison, DM², Tammy Schuler, PhD^3*, Djibril Liassou, MSc^3*, Marné Garretson, MPH^3*, Sankar Mahadevan, MEng, MBA^4*, Ali McBride⁴, Derek Tang, PhD^4*, Irene S. DeGutis^4*, Pranav Abraham, PhD^4* and Aaron T. Gerds, MD, MS⁵

¹Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
²Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom
³Cardinal Health Specialty Solutions, Dublin, OH
⁴Bristol Myers Squibb, Princeton, NJ
⁵Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Rushil V. Patel, MD¹, Danielle Boselli, MS^2*, Patrick L Meadors, PhD^3*, Stephanie Begley, MS^2*, Rupali Bose, MS, MBA^2*, Jing Ai, MD, PhD⁴, Brittany Knick Ragon, MD⁴, Srinivasa Reddy R. Sanikommu, MD⁴, Nilay A. Shah, MD^4*, Thomas G. Knight, MD⁴, James T. Symanowski, PhD^2*, Declan Walsh, MD, MSc, FACP, FRCP^3*, Michael R. Grunwald, MD⁴ and Aleksander L. Chojecki, MD⁴

¹Department of Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC
²Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC
³Department of Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁴Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC

Ian M. Bouligny, MD¹, Graeme Murray^2*, Valerie Tran, MD^1*, Juhi Gor, MD^3*, Yiwei Hang^1*, Yanal Alnimer, MD^1*, Kyle Zacholski, PharmD^1*, Chad Venn, PharmD^1* and Keri Maher, DO⁴

¹Massey Cancer Center, Virginia Commonwealth University, Richmond, VA
²Massey Cancer Center, Viriginia Commonwealth University, Richmond, VA
³Virginia Commonwealth University, Richmond, VA
⁴Massey Cancer Center, Virginia Commonwealth University, Tucson, AZ

Karthika K V, DM^1*, Neeraj Sidharthan, MD, MBBS, DM, DNB², Anjana K V, MSc^3*, Remya Sudevan, MBBS MPH^4*, Ullas Mony, PhD^5*, Renjitha Bhaskaran, BSc^3*, Manoj Unni, MD DM^6*, Rema Ganapathy, MBBS DNB^7* and Nikhil Krishna Haridas, MBBS, MD, DNB^8*

¹Aster MIMS, Kozhikode, India
²Department of Clinical Hematology and Division of Stem Cell Transplantation, Amrita Institute of Medical Sciences , Amrita University, Kochi, Kerala, India
³Amrita Institute of Medical Sciences, Kochi, India
⁴Department of Public Health, Amrita institute of Medical Sciences, Kochi, India
⁵Centre of Molecular Medicine and Diagnostics (COMManD), Saveetha Dental College and Hospitals, Saveetha institute of medical and technical sciences, Chennai, Chennai, India
⁶Department of Clinical Hematology and Division of Stem Cell Transplantation, Amrita Institute of Medical Sciences, Kochi, India
⁷Department of Clinical Haematology, Amrita Institute of Medical Sciences, Kochi, India
⁸Clinical haematology, Amrita institute of Medical sciences, Kochi, India

Katharina M Lang, MD^1*, Tamás Bereczky, PhD^2*, Jan Geissler^3*, Natacha Bolanos^4*, Kathryn E. Morgan, MSc^5*, Ananda Plate, MSc^5*, Ana Vallejo, MSc^5*, Sophie Wintrich^6*, Nick York^7*, Peter Loffelhardt, DO^8*, Brian Huntly, MB ChB, FRCPath, FMedSci, PhD⁹, Pieter Sonneveld, MD¹⁰, Mario Boccadoro^11*, Valeria Santini, MD, PhD^12*, Šárka Pospíšilová^13*, Andreas Hochhaus¹⁴, Tiziano Barbui, MD^15*, Peter Borchmann¹⁶, Christian Buske, MD¹⁷, Yann Guillevic^18*, Frederico Calado^19*, Katy Harrison, PhD^20*, Dalia Dawoud^21*, Guillermo Sanz, MD, PhD^22,23,24, Jesús María Hernández^25*, Ellen De Waal^26*, Martje Barbus, PhD^27*, Renate Schulze-Rath^28* and Lars Bullinger, MD¹

¹Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Berlin, Germany
²LeukaNet, Riemerling, Germany
³Leukanet / representing the HARMONY Alliance Patient Cluster, Riemerling, Germany
⁴Lymphoma Coalition Europe, Paris, France
⁵Myeloma Patients Europe, Brussels, Belgium
⁶MDS UK Patient Support Group, London, United Kingdom
⁷CLLAN - CLL Advocates Network, Bern, Switzerland
⁸Asociación de Afectados por Neoplasias Mieloproliferativas, Barcelona, Spain
⁹University of Cambridge, Cambridge, ENG, United Kingdom
¹⁰Department of Hematology, Erasmus MC, Rotterdam, Netherlands
¹¹Division of Hematology, University of Torino, Torino, Italy
¹²Department of Experimental and Clinical Medicine, MDS Unit, Hematology, AOU Careggi - University of Florence, Firenze, Italy
¹³CEITEC, Brno, CZE
¹⁴Department of Internal Medicine 2, Hematology and Oncology, Jena University Hospital, Jena, Germany
¹⁵Research Foundation, Hospital Papa Giovanni XXIII, Bergamo, Italy,, BERGAMO, Italy
¹⁶Cologne Lymphoma Working Group, Department of Internal Medicine I, University Hospital of Cologne, Koeln, Germany
¹⁷Universtitätsklinikum Ulm, Ulm, Germany
¹⁸BMS, Steinhausen, Switzerland
¹⁹Novartis, Oncology Region Europe, Basel, Switzerland
²⁰National Institute for Health and Care Excellence, Manchester, United Kingdom
²¹NICE, London, United Kingdom
²²Hematology Deparment, Health Research Institute La Fe, Valencia, Spain
²³CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
²⁴Istituto de Investigación Sanitaria La Fe, Valencia, Spain
²⁵Centro de Investigación del Cáncer, Universidad de Salamanca-CSIC, Salamanca, Spain
²⁶European Hematology Association, Den Haag, NLD
²⁷AbbVie Deutschland GmbH & Co KG, Wiesbaden, DEU
²⁸Bayer AG, Pharmaceuticals Division, Berlin, Berlin, Germany

Allicia Girvan, PhD^1*, Junhua Yu, PhD^1*, Rajesh Kamalakar, MS^1*, Elizabeth S. Mearns, PharmD^2*, Michael Nixon, MSN, MPH^2* and Robert F. Cornell, MD, MS¹

¹AbbVie, Inc., North Chicago, IL
²Genentech, Inc., South San Francisco, CA

Connor Willis, PharmD^1*, David A. Sallman, MD², Malinda Tan, PharmD^1*, Madeline Brendle, MPH^1*, Vonetta L. Williams, PhD, MPH, CTR^2*, Craig Comperatore, MS^2*, Trang Au, MPH, PharmD^1*, Srinivas K. Tantravahi, MBBS³, Najla Al Ali, MS², Jeffrey A. Gilreath, PharmD^1,3, Tibor Kovacsovics, MD⁴, Xiting Cao, PhD^5*, Islam Sadek, MD^5*, Rami S. Komrokji² and David Stenehjem, PharmD^1,6*

¹Department of Pharmacotherapy, University of Utah, Salt Lake City, UT
²H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
³Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁴Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁵Novartis Pharmaceuticals Corporation, East Hanover, NJ
⁶Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota College of Pharmacy, Duluth, MN

Eva Telzerow^1*, Dennis Görlich, PhD^2*, Maria Cristina Sauerland, MSc^3*, Anna Sophia Moret^1*, Maja Rothenberg-Thurley^4*, Simon M. Krauss^5*, Friederike H. A. Mumm, MD^1*, Susanne Amler, PhD^6*, Wolfgang E. Berdel, MD⁷, Bernhard J. Wörmann, MD^8*, Utz Krug, MD⁹, Jan Braess, MD^10*, Pia Heußner, MD^11*, Wolfgang Hiddemann, MD, PhD¹, Karsten Spiekermann¹ and Klaus H. Metzeler, MD⁵

¹Department of Medicine III and Comprehensive Cancer Center (CCC Munich LMU), University Hospital, LMU Munich, Munich, Germany
²Institute of Biostatistics and Clinical Research, University of Muenster, Münster, Germany
³Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany
⁴Laboratory for Leukemia Diagnostics, Department of Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany
⁵Department of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany
⁶Friedrich-Loeffler-Institute, Institute of Epidemiology, Greifswald-Insel Riems, Germany
⁷Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
⁸Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany
⁹Department of Medicine III, Hospital Leverkusen, Leverkusen, Germany
¹⁰Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany
¹¹Departement of Internal Medicine, Hospital Garmisch-Partenkirchen, Garmisch-Partenkirchen, Germany

Ajeet Gajra, MD, MBBS¹, Jonathan K. Kish, PhD, MPH^2*, Alexander Russell-Smith, MSc^3* and Kristin M. Savill, PhD^2*

¹Hematology Oncology Associated, Central New York
²Cardinal Health Specialty Solutions, Dublin, OH
³Pfizer R&D Ltd, Sandwich, NY, United Kingdom

Qiufei Ma^1*, Xue Song^1*, Thomas E. Delea, MSIA^2*, Glenn S. Kroog, MD^1*, Wenzhen Ge^1*, Lei Chi^1*, Aaron Moynahan^2*, Derek Weycker, PhD^2* and Karen Rodriguez Lorenc, MD¹

¹Regeneron Pharmaceuticals, Inc., Tarrytown, NY
²Policy Analysis Inc (PAI), Cambridge, MA